Cite
HARVARD Citation
Zhou, Q. et al. (2016). Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial. Journal of hematology & oncology. 9 (1), pp. 1-8. [Online].